ArticlePoultry science2026
Metabolic markers linked to growth performance in Ross 708 broilers fed varying dietary crude protein levels.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A study was conducted to investigate the effects of dietary crude protein (CP) levels on plasma metabolome profiles and growth performance in 480 male 0-day-old Ross 708 broilers (n = 8). Broilers were fed three-phase corn-soybean meal-based diets from d 0 to 42, consisting of starter (d 0 to 14; 21.0, 22.5, and 24.0% CP), grower (d 15 to 28; 19.0, 20.5, and 22.0% CP), and finisher diets (d 29 to 42; 17.5, 19.0, and 20.5% CP for Low, Med, and High CP groups, respectively). Plasma was collected on d 42 for untargeted metabolomic profiling. On d 42, the Low CP group showed lower body weight compared to the Med CP group (P = 0.014), without changes in feed intake or feed conversion ratio. Increasing dietary CP quadratically changed body weight (P = 0.009) and overall feed intake (P = 0.035). Compared with the Med CP group, the Low CP group had significantly lower plasma levels of linolenic acid, phosphate, alanine, pseudouridine, and glycine, whereas the High CP group had higher phenylethylamine, γ-tocopherol, and aminomalonic acid but lower phosphate (P < 0.05). Pathway analysis showed that the Low CP diet altered alanine, aspartate, and glutamate metabolism (FDR < 0.001), associated with higher TCA cycle intermediates such as fumarate and succinate. The Low CP diet also altered beta-alanine metabolism and phenylalanine, tyrosine, and tryptophan metabolism (FDR < 0.05). The High CP diet altered galactose and branched-chain amino acid metabolism (FDR < 0.05). Pearson correlation analysis showed that body weight was positively correlated with plasma phosphate (r = 0.607, P = 0.002), alanine (r = 0.437, P = 0.049), and linolenic acid (r = 0.405, P < 0.05). In conclusion, a low protein diet is associated with coordinated alterations in amino acid and tricarboxylic acid cycle metabolism, whereas a high protein diet imposes an internal metabolic burden associated with surplus amino acid catabolism without growth benefits, with plasma phosphate acting as a strong growth marker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.